[The New York Times] $300,000 Drug

Jul 18, 2014

There is one other way that Kalydeco is an excellent example of personalized medicine: its cost. It’s more than $300,000 a year. Because patients will likely be taking the drug for the rest of their lives, it could cost millions of dollars to keep just one patient on Kalydeco. That raises another important question about the coming of personalized medicine.

How are we, as a society, going to pay for it?

[button title=”Read More” link=”http://www.nytimes.com/2014/07/19/opinion/joe-nocera-cystic-fibrosis-drug-price.html?_r=0” target=”_blank” size=”” color=”” class=””]